Cargando…
The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
Secretory Leukocyte Protease Inhibitor (SLPI) is a serine protease inhibitor produced by epithelial and myeloid cells with anti-inflammatory properties. Research has shown that SLPI exerts its anti-inflammatory activity by directly binding to NF-κB DNA binding sites and, in so doing, prevents bindin...
Autores principales: | McGarry, Niamh, Greene, Catherine M., McElvaney, Noel G., Weldon, Sinéad, Taggart, Clifford C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515294/ https://www.ncbi.nlm.nih.gov/pubmed/26247039 http://dx.doi.org/10.1155/2015/507315 |
Ejemplares similares
-
Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases
por: Molloy, Kevin, et al.
Publicado: (2019) -
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
por: Twigg, Matthew S., et al.
Publicado: (2015) -
Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
por: Taggart, Clifford C., et al.
Publicado: (2005) -
Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010) -
Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)